Targeting Points for Further Intervention: A Review of HIV-Infected Infants Born in Ireland in the 7 Years Following Introduction of Antenatal Screening
Free accessReview articleFirst published online July, 2008
Targeting Points for Further Intervention: A Review of HIV-Infected Infants Born in Ireland in the 7 Years Following Introduction of Antenatal Screening
Even in countries with well-developed programs for prevention of mother-to-child transmission (MTCT) of HIV, there remains a low level of ongoing transmission. Pregnant, HIV-infected women may not always access screening and available interventions because of circumstances, beliefs, and other influences. Missed opportunities for the prevention of MTCT remains an issue to be addressed. Through a review of HIV-infected children born during the years of antenatal screening in Ireland, we sought to identify further targets for intervention to further reduce MTCT.
Thorne C., Newell MLPrevention of mother-to-child transmission of HIV infection. Curr Opin Infect Dis. 2004;17:247-252.
2.
Foster CJ, Lyall EGH.HIV in pregnancy: evolution of clinical practice in the U.K. Int J STD AIDS. 2006; 17:660-667.
3.
Luzuriaga K. , Sullivan JLPaediatric HIV-1 infection: advances and remaining challenges. AIDS Rev. 2002;4: 21-26.
4.
Peters V., Liu KL, Dominguez K., et al. Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, pediatric spectrum of HIV disease cohort. Pediatrics. 2003;111(5, pt 2):1186-1191.
5.
Health Protection Surveillance Centre. (2007). Voluntary antenatal HIV testing in Ireland: results of the screening programme 2002 to 2006. http://www.ndsc.ie/hpsc/A-Z/HepatitisHIVAIDSandSTIs/HIVandAIDS/AntenatalHIVTesting/Report/File,2612,en.pdf.PublishedNovember2007. Accessed June 6, 2008.
6.
Central Statistics Office Ireland. (2006). Population and migration estimates in Ireland 2001 to 2006. http://www.cso.ie/releasespublications/pr_poparchive.htm . Accessed June 6, 2008.
7.
Lallemant M. , Jourdain G., Le Coeur S., et al. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. N Engl J Med. 2000;343:982-991.
8.
Read JS, Newell MKEfficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1. Cochrane Database Syst Rev.2005;19(4): CD005479.
9.
Shah I.Is elective cesarean section really essential for prevention of mother-to-child transmission of HIV in the era of antiretroviral therapy and abstinence of breast-feeding? J Trop Pediatr. 2006;52:163-165.
10.
Lyons F., Butler K., Coulter Smith S., et al. National guidelines for the management of HIV-1 in pregnancy . Ir Med J. 2006;99:152-154.
11.
British HIV Association. ( 2005). British HIV Association (BHIVA) guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission . http://www.neli.org.uk/IntegratedCRD.nsf/f3634a4f4e666ac58025704200401c20/9b342cbb179de70380256fff0060fee3?OpenDocument. Updated March 2005. Accessed June 6, 2008.
12.
Roongpisuthipong A., Siriwasin W., Simonds RJ, et al. HIV seroconversion during pregnancy and risk for mother to infant transmission. J Acquir Immune Defic Syndr. 2001;26:348-351.
13.
Nesheim S., Jamieson DJ, Danner SP, et al. Primary human immunodeficiency virus infection during pregnancy detected by repeat testing. Am J Obstet Gynecol. 2007;197:149e1-149e5.
14.
Bulterys M., Jamieson DJ, O'Sullivan MJ, et al. Rapid HIV-1 testing during labour: a multicentre study. JAMA. 2004;292:219-223.
15.
Ioannidis JPA , Abrams EJ, Ammann A., et al. Perinatal transmission of HIV-1 by pregnant women with RNA virus loads <1000 copies/mL. J Infect Dis. 2001;183:539-545.
16.
Bryson YJ, Luzuriaga K., Sullivan JL, et al. Proposed definitions for in utero versus intrapartum transmission of HIV-1. N Engl J Med. 1992;327:1246-1247.
17.
Magder LS, Mofenson L., Paul ME, et al. Risk factors for in utero and intrapartum transmission of HIV . J Acquir Immune Defic Syndr. 2005;38:87-95.